atorvastatin
accord healthcare limited - atorvastatin calcium trihydrate - film-coated tablet - atorvastatin calcium trihydrate 80 mg - lipid modifying agents
atorvastatin
accord healthcare limited - atorvastatin calcium trihydrate - film-coated tablet - atorvastatin calcium trihydrate 10 mg - lipid modifying agents
atorvastatin
accord healthcare limited - atorvastatin calcium trihydrate - film-coated tablet - atorvastatin calcium trihydrate 20 mg - lipid modifying agents
ezetimibe/atorvastatin gh 10/40 ezetimibe and atorvastatin (as calcium trihydrate) 10 mg/40 mg tablets blister pack
lupin australia pty limited - ezetimibe, quantity: 10 mg; atorvastatin calcium trihydrate, quantity: 41.363 mg (equivalent: atorvastatin, qty 40 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; sodium lauryl sulfate; sodium stearylfumarate; lactose; calcium carbonate; povidone; crospovidone; lactose monohydrate; hyprolose; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - prevention of cardiovascular disease ezetimibe/atorvastatin is indicated in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs) taking their maximum tolerated dose of atorvastatin and in need of additional lowering of ldl-c in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy,primary hypercholesterolaemia ezetimibe/atorvastatin is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients: ? not appropriately controlled with atorvastatin or ezetimibe alone; or ? already treated with atorvastatin and ezetimibe.,homozygous familial hypercholesterolaemia (hofh) ezetimibe/atorvastatin is indicated in patients with hofh. patients may also receive adjunctive treatments (eg. ldl apheresis).
ezetimibe sandoz
sandoz new zealand limited - ezetimibe 10mg; - tablet - 10 mg - active: ezetimibe 10mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate - ezetimibe sandoz administered with an hmg-coa reductase inhibitor (statin) or alone, is indicated as adjunctive therapy to diet for the reduction of elevated total cholesterol (total-c), low-density lipoprotein cholesterol (ldl-c), apolipoprotein b (apo b), and triglycerides (tg) and to increase high-density lipoprotein cholesterol (hdl-c) in adult and adolescent (10 to 17 years of age) patients with primary (heterozygous familial and non-familial) hypercholesterolaemia.
atozet ezetimibe/atorvastatin 10mg/40mg tablet blister pack
organon pharma pty ltd - ezetimibe, quantity: 10 mg; atorvastatin calcium trihydrate, quantity: 43.4 mg (equivalent: atorvastatin, qty 40 mg) - tablet, multilayer - excipient ingredients: hyprolose; lactose monohydrate; croscarmellose sodium; silicon dioxide; magnesium stearate; microcrystalline cellulose; povidone; polysorbate 80; sodium lauryl sulfate; calcium carbonate; titanium dioxide; macrogol 8000; hypromellose; purified talc - prevention of cardiovascular disease atozet is indicated in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs) taking their maximum tolerated dose of atorvastatin and in need of additional lowering of ldl-c in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy (see clinical trials). primary hypercholesterolaemia atozet is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients: - not appropriately controlled with atorvastatin or ezetimibe alone; - or already treated with atorvastatin and ezetimibe homozygous familial hypercholesterolaemia (hofh) atozet is indicated in patients with hofh. patients may also receive adjunctive treatments (e.g. ldl apheresis).
atorvastatin basics 30 mg film-coated tablets
basics gmbh hemmelrather weg 201 51377 leverkusen, germany - atorvastatin calcium, trihydrate - film-coated tablet - atorvastatin calcium trihydrate 30 mg - lipid modifying agents
atorvastatin basics 60 mg film-coated tablets
basics gmbh hemmelrather weg 201 51377 leverkusen, germany - atorvastatin calcium, trihydrate - film-coated tablet - atorvastatin calcium trihydrate 60 mg - lipid modifying agents
atorvastatin krka coated tablets 10mg
krka dd novo mesto Šmarješka cesta 6, 8501 novo mesto, slovenia - atorvastatin - film-coated tablet - atorvastatin 10 mg - lipid modifying agents
atorvastatin krka coated tablets 20mg
krka dd novo mesto Šmarješka cesta 6, 8501 novo mesto, slovenia - atorvastatin - film-coated tablet - atorvastatin 20 mg - lipid modifying agents